Guidelines for colonoscopy surveillance after cancer resection: A consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer

被引:231
作者
Rex, Douglas K.
Kahi, Charles J.
Levin, Bernard
Smith, Robert A.
Bond, John H.
Brooks, Durado
Burt, Randall W.
Byers, Tim
Fletcher, Robert H.
Hyman, Neil
Johnson, David
Kirk, Lynne
Lieberman, David A.
Levin, Theodore R.
O'Brien, Michael J.
Simmang, Clifford
Thorson, Alan G.
Winawer, Sidney J.
机构
[1] Indiana Univ, Sch Med, Indianapolis, IN 46204 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Amer Canc Soc, Atlanta, GA 30329 USA
[4] Univ Minnesota, Minneapolis, MN USA
[5] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[6] Univ Colorado, Denver, CO 80202 USA
[7] Harvard Univ, Sch Med, Boston, MA 02115 USA
[8] Univ Vermont, Burlington, VT USA
[9] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
[10] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[11] Univ Texas, SW Med Ctr, Dallas, TX 75230 USA
[12] Kaiser Permanente Med Ctr, Walnut Creek, CA USA
[13] Boston Univ, Sch Med, Boston, MA 02118 USA
[14] Creighton Univ, Omaha, NE 68178 USA
[15] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
10.1053/j.gastro.2006.03.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients with resected colorectal cancer are at risk for recurrent cancer and metachronous neoplasms in the colon. This joint update of guidelines by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer addresses only the use of endoscopy in the surveillance of these patients. Patients with endoscopically resected Stage I colorectal cancer, surgically resected Stages II and III cancers, and Stage IV cancer resected for cure (isolated hepatic or pulmonary metastasis) are candidates for endoscopic surveillance. The colorectum should be carefully cleared of synchronous neoplasia in the penoperative period. In nonobstructed colons, colonoscopy should be performed preoperatively. In obstructed colons, double-contrast barium enema or computed tomography colonography should be performed preoperatively, and colonoscopy should be performed 3 to 6 months after surgery. These steps complete the process of clearing synchronous disease. After clearing for synchronous disease, another colonoscopy should be performed in 1 year to look for metachronous lesions. This recommendation is based on reports of a high incidence of apparently metachronous second cancers in the first 2 years after resection. If the examination at 1 year is normal, then the interval before the next subsequent examination should be 3 years. If that examination is normal, then the interval before the next subsequent examination should be 5 years. Shorter intervals may be indicated by associated adenoma findings (see "Guidelines for Colonoscopy Surveillance After Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society"). Shorter intervals also are indicated if the patient's age, family history, or tumor testing indicate definite or probable hereditary nonpolyposis colorectal cancer. Patients undergoing low anterior resection of rectal cancer generally have higher rates of local cancer recurrence compared with those with colon cancer. Although effectiveness is not proven, performance of endoscopic ultrasound or flexible sigmoidoscopy at 3- to 6-month intervals for the first 2 years after resection can be considered for the purpose of detecting a surgically curable recurrence of the original rectal cancer.
引用
收藏
页码:1865 / 1871
页数:7
相关论文
共 66 条
[1]  
[Anonymous], 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002200
[2]   Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology [J].
Bampton, PA ;
Sandford, JJ ;
Cole, SR ;
Smith, A ;
Morcom, J ;
Cadd, B ;
Young, GP .
GUT, 2005, 54 (06) :803-806
[3]   Surveillance of colorectal cancer - Effectiveness of early detection of intraluminal recurrences on prognosis and survival of patients treated for cure [J].
Barillari, P ;
Ramacciato, G ;
Manetti, G ;
Bovino, A ;
Sammartino, P ;
Stipa, V .
DISEASES OF THE COLON & RECTUM, 1996, 39 (04) :388-393
[4]   The appropriate use of colonoscopy in the curative management of colorectal cancer [J].
Barrier, A ;
Houry, S ;
Huguier, M .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1998, 13 (02) :93-98
[5]  
Beets-Tan R G H, 2003, Colorectal Dis, V5, P392, DOI 10.1046/j.1463-1318.2003.00518.x
[6]   Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery [J].
Beets-Tan, RGH ;
Beets, GL ;
Vliegen, RFA ;
Kessels, AGH ;
Van Boven, H ;
De Bruine, A ;
von Meyenfeldt, MF ;
Baeten, CGMI ;
van Engelshoven, JMA .
LANCET, 2001, 357 (9255) :497-504
[7]   2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines [J].
Benson, AB ;
Desch, CE ;
Flynn, PJ ;
Krause, C ;
Loprinzi, CL ;
Minsky, BD ;
Petrelli, NJ ;
Pfister, DG ;
Smith, TJ ;
Somerfield, MR .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) :3586-3588
[8]  
Bond JH, 2000, AM J GASTROENTEROL, V95, P3053
[9]   CUMULATIVE INCIDENCE OF METACHRONOUS COLORECTAL-CANCER [J].
CALI, RL ;
PITSCH, RM ;
THORSON, AG ;
WATSON, P ;
TAPIA, P ;
BLATCHFORD, GJ ;
CHRISTENSEN, MA .
DISEASES OF THE COLON & RECTUM, 1993, 36 (04) :388-393
[10]  
CARLSSON G, 1987, ARCH SURG-CHICAGO, V122, P1261